Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
Showing public results only.
AIFU still has a large China insurance distribution platform, with 42,170 registered agents and 313 sales outlets, but the 2025 Form 20-F shows a severe revenue and asset-quality reset before a 2026 acquisition added dark tea inventory, heavy share issuance an
OpenNIO's June 1 delivery release showed 37,705 May deliveries and 150,526 year-to-date deliveries. The stock now turns on whether ES9, ONVO L80, and firefly can keep Q1's margin inflection alive through June.
OpenMomentus says its cash position has jumped to about $76 million with no debt. The real question is whether Vigoride progress can become revenue before share-count math absorbs the upside.
OpenA filing-led diligence review of Datavault AI, focused on revenue quality, cash conversion, dilution, tokenization claims, GPU deployment proof, and validation gates.
Open20/20 Biolabs has a real OneTest cancer-screening revenue base and a fresh Nasdaq listing, but FY2025 losses, negative cash flow, Streeterville financing and resale overhang keep AIDX in a high-risk coverage bucket.
OpenAscent Industries is trying to turn a cash-rich post-divestiture shell into a focused specialty chemicals platform, with Q1 revenue growth, no revolver debt, aggressive buybacks, a Midwest packaging-chemistry acquisition, and unresolved proof gates around marg
OpenRobo.ai is trying to move from a failed smart-EV revenue base into an AI robotics, intelligent hardware and asset platform. The filings show FY2025 revenue of only $0.95 million, a $167.3 million net loss, $4.1 million of cash, $124.6 million of liabilities, n
OpenForafric owns real Morocco and West Africa milling assets, but the current stock story is a very-high-risk turnaround: H1 revenue collapsed, the 2025 annual report is late, going-concern language is live, and the newest strategic pivot needs hard proof.
OpenAudioEye sits in a useful corner of software: websites and mobile apps keep needing accessibility testing, monitoring and remediation. The appeal is $41.2 million of ARR, about 78% GAAP gross margin and positive operating cash flow. The catch is that AEYE is s
OpenAeries has turned fiscal 2026 adjusted EBITDA positive and sells an AI-enabled GCC model to private-equity and middle-market clients, but the latest filings also show going-concern doubt, Nasdaq delisting proceedings, FPA obligations and control weaknesses.
OpenAntelope Enterprise has a Nasdaq listing, China livestream e-commerce revenue, Bitcoin financing, fresh share issuance, and a planned energy-supply launch. The catch is the filed operating base: $60.8 million of transition-period revenue produced just $131,000
OpenADTRAN's fiber and optical-networking rebound is finally visible in official numbers, but the next decision point is whether gross margin, cash conversion, debt, and Adtran Networks obligations let common shareholders keep the upside.
OpenAcme United looks like a sleepy tools business until the filing mix shows first aid at roughly two-thirds of sales, a new My Medic deal, tariff pain, rising debt, and a customer-concentration test.
OpenOfficial-source baseline for Able View Global using SEC submissions, SEC company facts, the FY2025 Form 20-F, H1 2025 Form 6-K interim statements, December 2025 and March 2026 Forms 6-K, and official peer filings.
OpenAurora is trying to leave the worst cannabis-stock habits behind: Q3 FY2026 medical cannabis revenue set a record, management is exiting weaker Canadian consumer lanes, and the balance sheet has cash. The catch is that IFRS losses, Bevo restructuring, internal
Open